Evidence map›Paper›PMID 37577497›Full record

ArticlebioRxiv : the preprint server for biology2023

A genetic basis for cancer sex differences revealed in Xp11 translocation renal cell carcinoma.

Mingkee Achom, Ananthan Sadagopan, Chunyang Bao, Fiona McBride, Qingru Xu, Prathyusha Konda, Richard W Tourdot, Jiao Li, Maria Nakhoul, Daniel S Gallant and 10 more

Open access · greenAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 2 countries.

Mingkee AchomDepartment of Medical Oncology, Dana-Farber Cancer Institute; Boston, MA, USA.
Ananthan SadagopanDepartment of Medical Oncology, Dana-Farber Cancer Institute; Boston, MA, USA.
Chunyang BaoDepartment of Data Science, Dana-Farber Cancer Institute; Boston, MA, USA.
Fiona McBrideDepartment of Biomedical Informatics, Blavatnik Institute, Harvard Medical School; Boston, MA, USA.
Qingru XuDepartment of Medical Oncology, Dana-Farber Cancer Institute; Boston, MA, USA.
Prathyusha KondaDepartment of Medical Oncology, Dana-Farber Cancer Institute; Boston, MA, USA.
Richard W TourdotDepartment of Data Science, Dana-Farber Cancer Institute; Boston, MA, USA.
Jiao LiDepartment of Medical Oncology, Dana-Farber Cancer Institute; Boston, MA, USA.
Maria NakhoulDepartment of Informatics & Analytics, Dana-Farber Cancer Institute; Boston, MA, USA.
Daniel S GallantDepartment of Medical Oncology, Dana-Farber Cancer Institute; Boston, MA, USA.
Usman Ali AhmedDepartment of Medical Oncology, Dana-Farber Cancer Institute; Boston, MA, USA.
Jillian O'TooleDepartment of Medical Oncology, Dana-Farber Cancer Institute; Boston, MA, USA.
Dory FreemanDepartment of Medical Oncology, Dana-Farber Cancer Institute; Boston, MA, USA.
Gwo-Shu Mary LeeDepartment of Medical Oncology, Dana-Farber Cancer Institute; Boston, MA, USA.
Jonathan L HechtDepartment of Pathology, Beth Israel Deaconess Medical Center; Boston, MA, USA.
Eric C KauffmanDepartment of Urology, Roswell Park Comprehensive Cancer Center; Buffalo, New York, USA.
David J EinsteinDivision of Medical Oncology, Beth Israel Deaconess Medical Center; Boston, MA, USA.
Toni K ChoueiriDepartment of Medical Oncology, Dana-Farber Cancer Institute; Boston, MA, USA.
Cheng-Zhong ZhangDepartment of Data Science, Dana-Farber Cancer Institute; Boston, MA, USA.
Srinivas R ViswanathanDepartment of Medical Oncology, Dana-Farber Cancer Institute; Boston, MA, USA.
Dana-Farber Cancer Institute · USBroad Institute · USHarvard University · USBeth Israel Deaconess Medical Center · USBoston Biomedical Research Institute · USBrigham and Women's Hospital · USRoswell Park Comprehensive Cancer Center · US

Funding

VectorP30CA006516 · NCI · DANA-FARBER CANCER INSTITUTE · PI Irene M. Ghobrial · 1985 to 2026
$330.6M
Treating the P13-Kinase/AKTP50CA101942 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI David McDermott · 2003 to 2026
$53.4M
Center for the Comprehensive Analysis of Cancer Somatic Copy-Number Alterations, Rearrangements, and Long-Read Sequencing DataU24CA264029 · NCI · BROAD INSTITUTE, INC. · PI BEROUKHIM, RAMEEN, CHERNIACK, ANDREW DAVID · 2021 to 2025
$1.9M
NCI NIH HHS P30 CA006516NCI NIH HHS P50 CA101942NCI NIH HHS U24 CA264029
6 · The paper itself

Abstract

Xp11 translocation renal cell carcinoma (tRCC) is a female-predominant kidney cancer driven by translocations between the

Identifiers

PMID37577497
PMCPMC10418269
OpenAlexW4385612632

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.